Cargando…
Immunosuppression in Renal Transplantation and Dyslipidemia, Which Factors Should Be Considered?
Autores principales: | De Giorgi, Alfredo, Fabbian, Fabio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955281/ https://www.ncbi.nlm.nih.gov/pubmed/24693514 http://dx.doi.org/10.5812/numonthly.14189 |
Ejemplares similares
-
Should physicians always rely on estimated glomerular filtration rate without knowing the equation?
por: Fabbian, Fabio, et al.
Publicado: (2017) -
Dyslipidemia in Renal Transplant Recipients Treated With Cyclosporine A
por: Niemczyk, Mariusz
Publicado: (2013) -
Unrevealing of Primary Vesicoureteral Reflux which is Not Harmful for Kidneys in Children Should Be Considered as Success
por: Kavukcu, Salih, et al.
Publicado: (2013) -
Dyslipidemia in Transplant Patients: Which Therapy?
por: Iannuzzo, Gabriella, et al.
Publicado: (2022) -
Reducing the risk of venous thromboembolism using apixaban – patient perspectives and considerations. Should more attention be given to females?
por: Fabbian, Fabio, et al.
Publicado: (2016)